{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000718","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2026-05-13T20:45:41+00:00","discovered_at":"2026-05-13T20:47:00.323439+00:00","generated_at":"2026-05-13T21:12:28.413346+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Stockholders approve reverse stock split at ratio of 1-for-3 to 1-for-30","bullets":["Proposal 1 (reverse split) approved: 13,571,288 for, 1,153,415 against, 61,177 abstentions.","Proposal 2 (adjournment) approved: 13,626,029 for, 1,091,528 against, 68,323 abstentions.","Exact split ratio between 1:3 and 1:30 to be set by Board; intended to regain Nasdaq bid price compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000718","json":"https://secwatch.observer/filing/0001731122-26-000718.json","markdown":"https://secwatch.observer/filing/0001731122-26-000718.md","text":"https://secwatch.observer/filing/0001731122-26-000718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000718/0001731122-26-000718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112226000718/e7639_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T21:12:28.413346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}